X4 Pharmaceuticals, Inc. Common Stock (NASDAQ: XFOR) last traded at $4.04, up 0.25% on the session. The quote above updates while this page is open; the figures below are drawn from X4 Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
X4 Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker XFOR. Its market capitalisation is $400.55 million.
Valuation measures for X4 Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $400.55M |
|---|---|
| Enterprise value | $303.07M |
| Price / sales | 25.28 |
| Price / book | 2.58 |
| Beta | 1.74 |
Trailing-twelve-month figures tagged in X4 Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $15.85M |
|---|---|
| Net income (TTM) | -$90.14M |
| Operating margin | -554.71% |
| Return on equity | -57.98% |
| Cash | $195.09M |
Range and volume for XFOR over the past 52 weeks.
| 52-week high | $4.83 |
|---|---|
| 52-week low | $2.80 |
| Volume | 1.22M |
| Average volume | 764.6K |
| Previous close | $4.03 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.